Fig. 3
From: Circulating innate lymphoid cells are dysregulated in patients with prostate cancer
A–C ILC activation is affected in patients with PCa. IL-33 (A), IL-18 (B), and PGD2 (C) concentrations (pg/ml) in sera of HDs (n = 8) and patients with LG (n = 11–15) and HG (n = 24) PCa. D. Correlation between IL-33 and IL-18 levels in PCa via TIMER database. E, F Expression of IL1RL1 (E) and IL18R1 (F) assessed by qPCR in freshly sorted ILC2s from HDs and patients with LG and HG PCa (n = 3). Data shown as mean ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001) and analyzed by Wilcoxon and/or one-way ANOVA tests